Nuvectis Pharma, Inc. (NVCT) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
the bull case· 3
4
disclosed supplier and customer ties in SEC filings with counterparties
sec filingsedgar1 of 16
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '26+26.59%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26the bear case· 3
7 of 7
recent reports where the move came in under the options-implied range
earnings historyimplied vs realized3
of the funds on file reporting a position in NVCT
n-portas of Jun 30 '2613
managers whose positions together make up four fifths of the reported value
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 3 '26 report. Not a forecast, not advice.
Of the 4 companies Nuvectis Pharma, Inc. moves with most closely, none share its SEC classification.
Measured against 500 trading days of our own closes. Co-movement, not cause.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
85 managers report a position worth $195.8M between them, and 13 of them hold 80% of it.
NVCT (Nuvectis Pharma, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
Nuvectis Pharma, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
High 22.63 at 3:15 pm ET, low 21.22 at 11:00 am ET.